Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.
about
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyPredictive and prognostic molecular markers for cancer medicineClinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.Prognostic factors in renal cell and bladder cancer.The genetics of transitional cell carcinoma: progress and potential clinical application.What we could do now: molecular pathology of bladder cancer.Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladderInactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.Low ANXA10 expression is associated with disease aggressiveness in bladder cancerDifferential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implicationsUrinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.Expression of the retinoblastoma protein is regulated in normal human tissuesp53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancerp53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.Retinoblastoma gene mutations in primary human bladder cancerExpression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Developing innovative strategies for advanced transitional cell carcinoma of the bladder.G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer.Molecular markers for bladder cancer: the road to a multimarker approach.Predicting survival after radical cystectomy for bladder cancer.Molecular biomarkers in urothelial bladder cancer.Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix.Bladder cancer subtypes defined by genomic alterations.Biomarkers in bladder cancer: present status and perspectives.Targeted therapies in the management of metastatic bladder cancerAdjuvant and neoadjuvant radiotherapy for bladder cancer: revisited.Prognostic value of cell-cycle regulation biomarkers in bladder cancer.Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumoursMolecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.Partial allelotype of schistosomiasis-associated bladder cancer.Recent advances in the molecular genetics of urogenital tumors.The retinoblastoma gene and its significance.
P2860
Q24604540-A6EEC90C-2122-4558-BE68-B85269906093Q28743108-E322340A-3DAC-40DB-B4EE-9B33DC7A34D6Q33403088-EF6F43B6-F66A-4129-91B7-D5C605289578Q33658216-67A60A05-8051-4908-8A34-FF65134E3C31Q33723575-66641AC3-FE2E-4CF6-B493-C1BB8994425CQ33918737-ACCCC278-088C-40AC-8D12-A2D3D3292F6EQ33919299-982AF490-7E7E-4E96-A9E7-DB76EE59F5E6Q34585359-7D6E41A0-A10F-48E7-AC3E-BC368D0D1C80Q34866510-A06A4723-99F2-4A85-AE27-DF19FEADD54EQ35620687-4F64E02F-684D-4639-85EE-418A4B06E772Q35764748-54173EB3-96E2-41A8-9F64-D5698B2C0CB2Q35786303-05955533-0CB3-4BFD-9E98-BBEF66A3F3F6Q35798342-A6B64493-69FD-4C23-BA55-A74114919391Q35833302-3029A231-5C7C-4E83-8B3A-69D39BF9B4DDQ35833475-2DB975F2-2B70-4A86-AB17-4B875FEBE541Q36079809-F23520EE-B2AB-4D56-9B3E-F55B568BF28FQ36080738-EAEBF8E6-73E7-4E03-B237-347E01D47DEBQ36080777-20ED3181-EE05-462B-93ED-E5DFBAFB0E58Q36081239-F98B2D15-BFA1-4B28-9703-4854BF3BDC6CQ36341182-E35886F1-2E4F-4A5B-AC78-63A86E804156Q36352085-D55AD56F-5414-449C-86D8-75F28CD6773FQ36618000-9DC9BC48-90F0-4A14-A8EB-0C5CCA6D7813Q36622949-4872DA1C-012A-45BB-84AE-BA846F6D3CA3Q36659782-EB0BA848-7E61-429A-B2E0-DD6648B06BD0Q36670961-41D78A8F-5B79-4D30-80B1-9BC5EA58FB4CQ37025942-07187481-2E32-44C6-82C8-32AE27C50FCEQ37103989-11403255-31FB-4667-A6B3-1B55F342186BQ37123497-8948B95C-0810-4872-87C3-5F965602EEB3Q37208102-8A659FCA-DF33-4D0B-AFF3-1953247CC8D4Q37278990-4530DF54-F7F7-4F52-8FC6-78FB94FCE4B0Q37281006-0CC3982A-C50A-48D8-B4F5-BAE68D8FC7F0Q37290448-E0B6D44E-6461-4AB7-8594-DF01CACECC70Q37771961-99328169-7900-4B61-B063-0D5824560E1AQ38049692-AB3AF099-870A-427F-908A-79C6B02285B0Q38230912-9B21D771-22A8-4A89-BFED-31B14035CEB5Q38302408-1AA467AA-157F-49FC-93F1-49DF3CE33D29Q38478886-DDCBE604-25EB-4B45-B3FA-1AEB61523D63Q39453777-8A52806E-BEBD-4D0F-951D-10D534A3F219Q40456228-5C85518D-F302-422E-B37F-F8BD8BC85661Q40696376-A08B443B-5077-4782-9178-B82557CA40CE
P2860
Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Altered expression of retinobl ...... cally advanced bladder cancer.
@en
type
label
Altered expression of retinobl ...... cally advanced bladder cancer.
@en
prefLabel
Altered expression of retinobl ...... cally advanced bladder cancer.
@en
P2093
P356
P1476
Altered expression of retinobl ...... cally advanced bladder cancer.
@en
P2093
Benedict WF
Logothetis CJ
P304
P356
10.1093/JNCI/84.16.1256
P407
P577
1992-08-01T00:00:00Z